Related content

Neuropsychiatric Toxicity of Antiviral Treatment in Chronic Hepatitis C

By  

Digestive Diseases, Vol. 18, Iss. 3, 2001-03 ,pp. : 107-116

Karger

Access to resources Recommend Favorite

DrugDrug Interactions and Drug Resistance Will Limit Access to Treatment in Patients With HIV and Hepatitis C Virus Coinfection

By Marks Michael   Kulasegaram Ranjababu  

Clinical Infectious Diseases, Vol. 57, Iss. 1, 2013-07 ,pp. : 156-157

Oxford University Press

Access to resources Recommend Favorite

Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin

By Potthoff A.   Berg T.   Wedemeyer H.  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 12, 2009-12 ,pp. : 1487-1490

Informa Healthcare

Access to resources Recommend Favorite

Insulin Resistance and Response to Antiviral Therapy in Chronic Hepatitis C: Mechanisms and Management

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 285-293

Karger

Access to resources Recommend Favorite

Quasispecies as Predictive Response Factors for Antiviral Treatment in Patients with Chronic Hepatitis C

By Salmerón Javier   Rueda Paloma   Ruiz-Extremera Ángela   Casado Jorge   Huertas Carlos   Bernal Maria   Rodríguez Luis   Palacios Ángel  

Digestive Diseases and Sciences, Vol. 51, Iss. 5, 2006-05 ,pp. : 960-967

Springer Publishing Company

Access to resources Recommend Favorite